betulinic acid has been researched along with bevirimat in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CH; Cosentino, LM; Garrett, PE; Hashimoto, F; Kashiwada, Y; Lee, KH | 1 |
| Chen, CH; Cosentino, LM; Kashiwada, Y; Lee, KH; Shen, JK; Sun, IC; Wang, HK; Yang, LM | 1 |
| Cosentino, LM; Hashimoto, A; Ikeshiro, Y; Kashiwada, Y; Lee, KH; Nagao, T; Okabe, H | 1 |
| Allaway, GP; Fujioka, T; Ikeshiro, Y; Kashiwada, Y; Kilgore, NR; Lee, KH; Sekiya, M; Wild, CT | 1 |
| Lee, KH; Nakagawa-Goto, K; Taniguchi, M; Tokuda, H; Yamada, K | 1 |
| Chen, CH; Dang, Z; Ho, P; Huang, L; Lai, W; Lee, KH; Qian, K | 1 |
| Lee, KH | 1 |
| Bori, ID; Chen, CH; Huang, L; Lee, KH; Qian, K | 1 |
| Bouaziz, S; Briant, L; Chazal, N; Coric, P; Gay, B; Royer, J; Souquet, F; Turcaud, S | 1 |
| Talele, TT | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Goto, T; Gotoh, K; Kanamoto, T; Kanbara, K; Kashiwada, Y; Nakashima, H; Sano, K; Yoshimori, M | 1 |
| Stix, G | 1 |
| Chen, CH; Ho, P; Huang, L | 1 |
| Ablan, S; Durell, SR; Freed, EO; Gaur, R; Ghimire, D; Kaplan, JA; Kuruppu, N; Mandt, R; Martin, DE; Nitz, TJ; Pham, P; Timilsina, U; Urano, E; Wild, CT | 1 |
2 review(s) available for betulinic acid and bevirimat
| Article | Year |
|---|---|
Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach.
Topics: Anti-HIV Agents; Biological Factors; Drug Design; Molecular Structure; Pharmaceutical Preparations; Plants, Medicinal | 2010 |
Natural-Products-Inspired Use of the gem-Dimethyl Group in Medicinal Chemistry.
Topics: Animals; Biological Products; Chemistry, Pharmaceutical; Humans | 2018 |
13 other study(ies) available for betulinic acid and bevirimat
| Article | Year |
|---|---|
Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents.
Topics: Antiviral Agents; Betulinic Acid; Giant Cells; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Structure; Pentacyclic Triterpenes; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Structure-Activity Relationship; Triterpenes; Virus Replication | 1996 |
Anti-AIDS agents. 34. Synthesis and structure-activity relationships of betulin derivatives as anti-HIV agents.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Cell Fusion; Cell Line; Glutarates; HeLa Cells; HIV-1; Humans; Lymphocytes; Mice; Structure-Activity Relationship; Triterpenes; Virus Replication | 1998 |
Anti-AIDS agents 38. Anti-HIV activity of 3-O-acyl ursolic acid derivatives.
Topics: Anti-HIV Agents; Cell Line; HIV-1; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Spectrometry, Mass, Fast Atom Bombardment; Triterpenes; Ursolic Acid | 2000 |
3-O-Glutaryl-dihydrobetulin and related monoacyl derivatives as potent anti-HIV agents.
Topics: Anti-HIV Agents; HIV-1; Humans; Triterpenes | 2004 |
Cancer preventive agents 9. Betulinic acid derivatives as potent cancer chemopreventive agents.
Topics: Anticarcinogenic Agents; Antigens, Viral; Betulinic Acid; Cell Line, Tumor; Esterification; Humans; Pentacyclic Triterpenes; Tetradecanoylphorbol Acetate; Triterpenes | 2009 |
Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors.
Topics: Anti-HIV Agents; Betulinic Acid; Cell Line; Dose-Response Relationship, Drug; HIV-1; HIV-2; Humans; Inhibitory Concentration 50; Pentacyclic Triterpenes; Triterpenes | 2009 |
Anti-AIDS agents 90. novel C-28 modified bevirimat analogues as potent HIV maturation inhibitors.
Topics: Anti-HIV Agents; Cell Line; Drug Design; Drug Stability; HIV-1; Humans; Structure-Activity Relationship; Succinates; Triterpenes; Virus Replication | 2012 |
Synthesis and biological evaluation of a new derivative of bevirimat that targets the Gag CA-SP1 cleavage site.
Topics: Anti-HIV Agents; Binding Sites; Dose-Response Relationship, Drug; gag Gene Products, Human Immunodeficiency Virus; HEK293 Cells; HIV-1; Humans; Microbial Sensitivity Tests; Structure-Activity Relationship; Succinates; Triterpenes | 2013 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation.
Topics: Anti-HIV Agents; Betulinic Acid; Cell Fusion; Formazans; Giant Cells; HIV-1; Humans; Microbial Sensitivity Tests; Pentacyclic Triterpenes; Tetrazolium Salts; Time Factors; Triterpenes; Tumor Cells, Cultured; Viral Proteins; Virion | 2001 |
A new assault on HIV.
Topics: Anti-HIV Agents; Betulinic Acid; Clinical Trials as Topic; Drug Interactions; Drug Resistance, Viral; Drugs, Chinese Herbal; Gene Products, gag; HIV; Humans; Pentacyclic Triterpenes; Succinates; Triterpenes; Virus Cultivation | 2006 |
Activation and inhibition of the proteasome by betulinic acid and its derivatives.
Topics: Betulinic Acid; Cell Line, Tumor; Chymotrypsin; Enzyme Activation; Humans; Pentacyclic Triterpenes; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Succinates; Triterpenes | 2007 |
Resistance to Second-Generation HIV-1 Maturation Inhibitors.
Topics: Anti-HIV Agents; Betulinic Acid; Capsid; Capsid Proteins; Cell Line; Drug Resistance, Viral; gag Gene Products, Human Immunodeficiency Virus; HIV Seropositivity; HIV-1; Humans; Jurkat Cells; Mutation; Pentacyclic Triterpenes; Succinates; Triterpenes; Virion; Virus Assembly; Virus Replication | 2019 |